Scientist at the Columbia University College of Physicians and Surgeons in New York have published a new study on the potential use of cannabinoids in the treatment of brain cancer. Doctors Ivanov, Wu and Hei at the Center for Radiological Research, have published a study in the oncology journal Oncotarget (2017 May: Abstract) – on the efficacy of using cannabinoids to facilitate the treatment of brain cancer.
Imagine a life constantly in pain. Throw in some extreme tiredness, plus feeling like your whole body is on fire, and that is a roundabout description of fibromyalgia. Not surprisingly many sufferers also experience low mood, depression and anxiety as their once active lives become a living hell. More often than not the cocktail of drugs prescribed fail to keep symptoms in check and are accompanied by hard to bear side effects. So increasingly, many fibromyalgia patients are turning to medical cannabis, in particular CBD.
Until very recently, CBD has lived in the shadow of its infamous cannabinoid cousin, THC, which is widely known as the high-inducing compound in Marijuana. However, extensive research is now being conducted on CBD and its medical potential, which has opened the doors for antipsychotic, anticancer and anti inflammatory treatment options among many others. One after another, scientists are publishing studies that prove CBD is the most dynamic and useful of the cannabinoids as far as promotion of proper function of the systems of the body is concerned.
(This story appears in the July issue of Marijuana Business Magazine.) Just as the marijuana industry has exploded in recent years, so too has a sector that revolves around the plant’s non-psychoactive cousin: hemp. In particular, demand for hemp-based cannabidiol has skyrocketed, especially since a 2013 CNN report...